VENADO represents an entirely new product family in K2M's growing biologics portfolio, already featuring VIKOS® Allograft Systems and VESUVIUSTM Osteobiologic Systems.

Company Marks Ascent to Largest Privately Held Spinal Device Company with Ongoing Commitment to Growth through Innovation

New Indication will Provide New Treatment Option for Scoliosis in Younger Patients

K2M Brings Together Focus on Complex Spinal Pathologies & Minimally Invasive Procedures in One System

K2M, Inc. announced a partnership with Cadwell Laboratories, Inc. to provide a neuromonitoring solution for the company's RAVINE® Lateral Access System.

K2M Advances Spinal Deformity Market with MESA Rail™ Deformity Spinal System

Recent additions of BLUE RIDGE™ Hybrid and PYRENEES® Translational to K2M's product offerings enable the company to address all segments of the cervical fixation market

K2M, Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the SANTORINI™ Corpectomy Cage Systems.